BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 7, 2016
View Archived Issues
drNPCs to treat neurological disorders
Read More
SPR-741 potentiates antibiotics against multidrug-resistant Gram-negative infections
Read More
FDA approves Abbott's Absorb absorbable stent for coronary heart disease
Read More
Arbutus Biopharma issues notice of termination to NeuroVive for NVP-018
Read More
FDA grants orphan drug designation for iBio-CFB03
Read More
Oryzon Genomics selects LSD1 inhibitor for preclinical development
Read More
Aviragen to license, develop and commercialize RSV inhibitors
Read More
Midostaurin shows promising clinical results for advanced systemic mastocytosis
Read More
Actelion initiates phase III TOMORROW study to evaluate macitentan in children with PAH
Read More
FDA grants fast track status to Merrimack's seribantumab
Read More
Takeda receives E.U. marketing authorization for Adcetris in third indication
Read More
Vertex, Moderna sign exclusive collaboration agreement for development of mRNA therapeutics for CF
Read More
Tolerogenic nanoparticles suppress spontaneous development of T1D in NOD mice
Read More
Bio-Techne to acquire Advanced Cell Diagnostics
Read More
ADT Pharmaceuticals announces RAS Gtpase inhibitors
Read More
Merck & Co. patents orexin receptor inhibitors
Read More
Roche and Genentech report ERalpha antagonists and destabilizers
Read More
Shanghai Haiyan Pharmaceutical Technology and Yangtze River Pharmaceutical disclose PI3K inhibitors
Read More
Celgene divulges ERK inhibitors
Read More
Alios BioPharma patents NS5B inhibitors
Read More
Revestive approved in Europe for pediatric patients with short bowel syndrome
Read More
Medivation enters confidentiality agreements with Sanofi and other companies
Read More
Amicus obtains rights to preclinical CDKL5 program through acquisition of MiaMed
Read More
FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria
Read More
New PREVAIL trial opens in Liberia for men with Ebola virus RNA detected in semen
Read More
Nanobiotix reports results for phase I/II trial of NBTXR-3
Read More
Asuragen launches AmplideX PCR/CE C9orf72 Kit
Read More
RHOA, CSNK1A1, DVL2, FZD8 and LRP5 may be useful as poor prognosis biomarkers in GC
Read More